Furthermore, IGF2BP2 is linked to tumor growth and poor outcome in other cancer types, such as HCC [15, 19], gallbladder cancer [20], pancreatic cancer [21], and glioblastoma [22–24]. The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.